Tuesday, October 26, 2021


Alkermes Commences Section 3 Trial of Platinum-Resistant Ovarian Most cancers Mixture Remedy

MT Newswires 2021 All information about ALKERMES PLC Analyst Suggestions on ALKERMES PLC …

By Staff , in Platinum , at October 26, 2021








MT Newswires 2021

All information about ALKERMES PLC

Analyst Suggestions on ALKERMES PLC

Gross sales 2021 1 170 M

Web revenue 2021 -81,5 M

Web money 2021 384 M

P/E ratio 2021 -64,2x
Yield 2021
Capitalization 5 130 M
5 130 M
EV / Gross sales 2021 4,06x
EV / Gross sales 2022 3,57x
Nbr of Workers 2 245
Free-Float 96,7%



Length :


Interval :




Alkermes plc Technical Analysis Chart | MarketScreener

Technical evaluation traits ALKERMES PLC

Brief Time period Mid-Time period Lengthy Time period
Tendencies Impartial Bullish Bullish



Earnings Assertion Evolution

Promote

Purchase

Imply consensus HOLD
Variety of Analysts 8
Final Shut Worth
31,80 $
Common goal value
28,38 $
Unfold / Common Goal -10,8%




Source link

Comments